The Discounted Cash Flow (DCF) valuation of Taiko Pharmaceutical Co Ltd (4574.T) is 167.15 JPY. With the latest stock price at 277.00 JPY, the upside of Taiko Pharmaceutical Co Ltd based on DCF is -39.7%.
Based on the latest price of 277.00 JPY and our DCF valuation, Taiko Pharmaceutical Co Ltd (4574.T) is a sell. selling 4574.T stocks now will result in a potential gain of 39.7%.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 7.1% | 6.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 136.15 - 261.15 | 167.15 |
| Upside | -50.8% - -5.7% | -39.7% |